Clincosm LogoSign in Get a demo

braf v600e

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liquid Biopsy, Melanoma (Skin), Melanoma Stage III Trial in Rome (Affinity Mediated Transport Amplification (AMT))

Recruiting
  • Liquid Biopsy
  • +4 more
  • Affinity Mediated Transport Amplification (AMT)
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jul 13, 2023

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

Recruiting
  • Cancer
  • +6 more
  • Indianapolis, Indiana
    Indiana University Hospital / IU Simon Cancer Center
Jan 12, 2023

BRAF V600E, Metastatic Colorectal Cancer Trial in China (Encorafenib, Cetuximab, FOLFIRI)

Recruiting
  • BRAF V600E
  • Metastatic Colorectal Cancer
  • Beijing, Beijing, China
  • +33 more
Dec 20, 2022

Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • (no location specified)
Aug 18, 2022

Malignant Melanoma, Metastatic Melanoma, Immunotherapy Trial (Pembrolizumab, Encorafenib, Binimetinib)

Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
Mar 31, 2022

Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI

Recruiting
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • +5 more
    • Aurora, Colorado
      University of Colorado, Cancer Center
    Nov 3, 2021

    Cancer, Lung Cancer Metastatic, BRAF V600E Trial in Seoul (daborafenib plus trametinib)

    Unknown status
    • Cancer
    • +2 more
    • daborafenib plus trametinib
    • Seoul, Korea, Republic of
      Asan Medical Center
    May 21, 2018